New chalcone incorporated structurally modified pyridine‐pyrimidine derivatives as anticancer agents: Their design, synthesis, and in‐vitro evaluation DOI

Swarupa Ketha,

Chithaluri Sudhakar,

Shashikala Kethireddy

et al.

Chemistry & Biodiversity, Journal Year: 2024, Volume and Issue: 21(12)

Published: Aug. 23, 2024

Abstract Chalcone‐incorporated pyridine‐pyrimidines i.e. derivatives of (5‐(6‐(pyrimidin‐5‐yl)pyridin‐3‐yl)thiophen‐2‐yl)prop‐2‐en‐1‐one were synthesized and their structures confirmed by analytical techniques. In addition, all the examined for capacity to fight against cancer towards four cell lines, including breast (MCF‐7), prostate (DU‐145 PC3), lung (A549) utilizing MTT technique clinically used chemotherapy medication, etoposide serving as a positive reference. All these results expressed in IC 50 μM, values compounds are compared with reference drug, showing ranging from 1.97±0.45 μM 3.08±0.135 μM. Among those, few 10(a–e ) demonstrated strong activities corresponding lines.

Language: Английский

Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities DOI

Wael A.A. Fadaly,

Mohamed T. M. Nemr,

Nesma M. Kahk

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 147, P. 107403 - 107403

Published: April 27, 2024

Language: Английский

Citations

22

Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity DOI
Amr H. Moustafa, Asmaa M. AboulMagd,

Ali M. Ali

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 147, P. 107410 - 107410

Published: April 27, 2024

Language: Английский

Citations

15

Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction DOI
Mohamed T. M. Nemr, Ahmed Elshewy, Mohammed L. Ibrahim

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 150, P. 107566 - 107566

Published: June 15, 2024

Language: Английский

Citations

15

Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023) DOI
Neha Bhatia, Suresh Thareja

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 151, P. 107607 - 107607

Published: July 4, 2024

Language: Английский

Citations

13

Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers DOI
Heba K. Abd El-Mawgoud, Asmaa M. AboulMagd, Mohamed T. M. Nemr

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 150, P. 107622 - 107622

Published: July 9, 2024

Language: Английский

Citations

13

Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies DOI

Wael A.A. Fadaly,

Fatma El Zahraa Ammar Mohamed, Mohamed T. M. Nemr

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 153, P. 107881 - 107881

Published: Oct. 10, 2024

Language: Английский

Citations

11

Insight Study For Repurposing Of Certain Anti‐Inflammatory Drugs Based On Aspirin and Salicylic Acid Scaffolds For The Treatment of Cancer as CDKs Inhibitors: Cheminformatics and Anticancer Studies DOI
Mohnad Abdalla, Ahmed E. Elmasry, Mohamed T. M. Nemr

et al.

ChemistrySelect, Journal Year: 2025, Volume and Issue: 10(15)

Published: April 1, 2025

Abstract The highly increased and global mortality due to cancer has created an urgent need discover promising targets for its treatment. Where drug repurposing was considered as attractive approach that can facilitate the lead generation optimization phases of discovery by existing agents target diseases other than their primary uses. Cheminformatics studies represented in molecular docking well dynamic simulation salicylic acid / aspirin analogues sulindac indomethacin anti‐inflammatory drugs were carried out be used cyclin‐dependent kinases (CDKs) namely CDK2, CDK6, CDK12 inhibitors. Sulindac displayed best binding ligand all receptors. CDKs inhibition effects three sulindac, anthranilic demonstrated good inhibitory activity against ranging from 0.48 1.78 µM. Likewise, cytotoxicity revealed potent anticancer 0.155 1.278 µM cell lines: HCT‐116, MCF‐7, HeLa cells. As a result, this technique saves lot time money order new agents.

Language: Английский

Citations

1

New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAF V600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study DOI Creative Commons

Wael A.A. Fadaly,

Mohamed T. M. Nemr,

Taha H. Zidan

et al.

Journal of Enzyme Inhibition and Medicinal Chemistry, Journal Year: 2023, Volume and Issue: 38(1)

Published: Dec. 7, 2023

A new series of bis-triazole 19a-l was synthesised for the purpose being hybrid molecules with both anti-inflammatory and anti-cancer activities assessed cell cycle arrest, NO release. Compounds 19c, 19f, 19h, 19 l exhibited COX-2 selectivity indexes in range 18.48 to 49.38 compared celecoxib S.I. = 21.10), inhibit MCF-7 IC50 9–16 μM tamoxifen (IC50 27.9 μM). showed good inhibitory activity against HEP-3B 4.5–14 sorafenib 3.5 μM) (HEP-3B). Moreover, derivatives 19e, 19j, 19k, HCT-116 5.3–13.7 5-FU 4.8 (HCT-116). excellent A549 3–4.5 6 (A549). aromatase 22.40, 23.20, 22.70, 30.30 μM), EGFR 0.112, 0.205, 0.169 0.066 B-RAFV600E 0.09, 0.06, 0.07 0.05

Language: Английский

Citations

18

Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs DOI Creative Commons
Sara Janowska, Serhii Holota, Roman Lesyk

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(2), P. 346 - 346

Published: Jan. 10, 2024

Aromatase is an enzyme that plays a crucial role in the biosynthesis of estrogens, which are hormones contribute to growth certain types breast cancer. In particular, aromatase catalyzes conversion androgens (male hormones) into estrogens (female various tissues, including adrenal glands, ovaries, and adipose tissue. Given estrogen promoting hormone-receptor-positive cancers, has become important molecular target for development anticancer agents. inhibitors can be classified two main groups based on their chemical structure: steroidal non-steroidal inhibitors. This work presents review literature from last ten years regarding search new We present directions search, taking account impact structure modifications activity.

Language: Английский

Citations

8

A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation DOI

Digambar Yevale,

Nishith Teraiya,

Twinkle Lalwani

et al.

Bioorganic Chemistry, Journal Year: 2023, Volume and Issue: 141, P. 106901 - 106901

Published: Oct. 1, 2023

Language: Английский

Citations

10